BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 38612507)

  • 1. Prognostic Value of Liquid-Biopsy-Based Biomarkers in Upper Tract Urothelial Carcinoma.
    Padullés B; Carrasco R; Ingelmo-Torres M; Roldán FL; Gómez A; Vélez E; Alfambra H; Figueras M; Carrion A; Gil-Vernet J; Mengual L; Izquierdo L; Alcaraz A
    Int J Mol Sci; 2024 Mar; 25(7):. PubMed ID: 38612507
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel Use of Circulating Tumor DNA to Identify Muscle-invasive and Non-organ-confined Upper Tract Urothelial Carcinoma.
    Huelster HL; Gould B; Schiftan EA; Camperlengo L; Davaro F; Rose KM; Soupir AC; Jia S; Zheng T; Sexton WJ; Pow-Sang J; Spiess PE; Daniel Grass G; Wang L; Wang X; Vosoughi A; Necchi A; Meeks JJ; Faltas BM; Du P; Li R
    Eur Urol; 2024 Mar; 85(3):283-292. PubMed ID: 37802683
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient-specific targeted analysis of circulating tumour DNA in plasma is feasible and may be a potential biomarker in UTUC.
    Mu N; Jylhä C; Axelsson T; Sydén F; Brehmer M; Tham E
    World J Urol; 2023 Dec; 41(12):3421-3427. PubMed ID: 37721600
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postoperative recurrence detection using individualized circulating tumor DNA in upper tract urothelial carcinoma.
    Tamura D; Abe M; Hiraki H; Sasaki N; Yashima-Abo A; Ikarashi D; Kato R; Kato Y; Maekawa S; Kanehira M; Takata R; Maejima K; Sasagawa S; Fujita M; Suzuki Y; Nakagawa H; Iwaya T; Nishizuka SS; Obara W
    Cancer Sci; 2024 Feb; 115(2):529-539. PubMed ID: 38083992
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative C-reactive protein to albumin ratio as a novel prognostic biomarker for the oncological outcomes of radical nephroureterectomy.
    Gwak CH; Suh J; Lim B; Song C; You D; Jeong IG; Hong JH; Hong B; Ahn H
    Urol Oncol; 2024 Feb; 42(2):30.e17-30.e23. PubMed ID: 38072737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper Urinary Tract Urothelial Cancer After Radical Cystectomy for Bladder Cancer: Survival Outcomes After Radical Nephroureterectomy.
    Ślusarczyk A; Zapała P; Piecha T; Zapała Ł; Borkowski T; Radziszewski P
    Ann Surg Oncol; 2024 Mar; 31(3):2144-2153. PubMed ID: 38085392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Perioperative circulating tumor DNA enables the identification of patients with poor prognosis in upper tract urothelial carcinoma.
    Nakano K; Koh Y; Yamamichi G; Yumiba S; Tomiyama E; Matsushita M; Hayashi Y; Wang C; Ishizuya Y; Yamamoto Y; Kato T; Hatano K; Kawashima A; Ujike T; Fujita K; Kiyotani K; Katayama K; Yamaguchi R; Imoto S; Imamura R; Nonomura N; Uemura M
    Cancer Sci; 2022 May; 113(5):1830-1842. PubMed ID: 35293110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten-year survival outcomes after radical nephroureterectomy with a risk-stratified approach using prior diagnostic ureteroscopy: a single-institution observational retrospective cohort study.
    Veeratterapillay R; Geraghty R; Pandian R; Roy C; Stenhouse G; Bird C; Soomro N; Paez E; Rogers A; Johnson M; Page T; Rix D; Thomas D; Rai BP
    BJU Int; 2022 Jun; 129(6):744-751. PubMed ID: 34726325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of Diagnostic Ureterorenoscopy on Intravesical Recurrence in Patients Undergoing Nephroureterectomy for Primary Upper Tract Urinary Carcinoma.
    İzol V; Deger M; Ozden E; Bolat D; Argun B; Baltaci S; Celik O; Akgul HM; Tinay İ; Bayazit Y;
    Urol Int; 2021; 105(3-4):291-297. PubMed ID: 33264798
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-Free DNA as a Prognostic Biomarker for Monitoring Muscle-Invasive Bladder Cancer.
    Carrasco R; Ingelmo-Torres M; Gómez A; Trullas R; Roldán FL; Ajami T; Moreno D; Rodríguez-Carunchio L; Alcaraz A; Izquierdo L; Mengual L
    Int J Mol Sci; 2022 Oct; 23(19):. PubMed ID: 36233035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What is the Role of the Preoperative Blood-Based Inflammation Biomarkers in the Prognosis of Upper Tract Urothelial Carcinoma With Radical Nephroureterectomy? A Single-Centre Retrospective Study.
    Luo Z; Jiao B; Huang T; Zhao H; Zhang G
    Technol Cancer Res Treat; 2022; 21():15330338221095667. PubMed ID: 35585719
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinoma.
    Hayashi Y; Fujita K; Matsuzaki K; Matsushita M; Kawamura N; Koh Y; Nakano K; Wang C; Ishizuya Y; Yamamoto Y; Jingushi K; Kato T; Kawashima A; Ujike T; Nagahara A; Uemura M; Imamura R; Takao T; Takada S; Netto GJ; Nonomura N
    Cancer Sci; 2019 May; 110(5):1771-1779. PubMed ID: 30887605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Histological variants and lymphovascular invasion in upper tract urothelial carcinoma can stratify prognosis after radical nephroureterectomy.
    Takemoto K; Hayashi T; Hsi RS; Kobatake K; Sekino Y; Kitano H; Ikeda K; Goto K; Hieda K; Sentani K; Kajiwara M; Nishizaka T; Teishima J; Oue N; Hinata N
    Urol Oncol; 2022 Dec; 40(12):539.e9-539.e16. PubMed ID: 36244916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic Impact of Preoperative Albumin-Globulin Ratio on Oncologic Outcomes in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy.
    Xu H; Tan P; Ai J; Huang Y; Lin T; Yang L; Wei Q
    Clin Genitourin Cancer; 2018 Oct; 16(5):e1059-e1068. PubMed ID: 29980449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic models for upper urinary tract urothelial carcinoma patients after radical nephroureterectomy based on a novel systemic immune-inflammation score with machine learning.
    Liu J; Wu P; Lai S; Wang J; Hou H; Zhang Y
    BMC Cancer; 2023 Jun; 23(1):574. PubMed ID: 37349696
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Gene Methylation and Clinical Factors in Non-Muscle-Invasive Upper Tract Urothelial Carcinoma After Radical Nephroureterectomy.
    Xing Y; Xiong G; Fang D; Yang X; Li X; Zhou L
    Clin Genitourin Cancer; 2016 Aug; 14(4):e371-8. PubMed ID: 27021587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Prognostic Value of Preoperative Naples Prognostic Score in Upper Tract Urothelial Carcinoma Patients after Radical Nephroureterectomy.
    Ye J; Chen Z; Pan Y; Liao X; Wang X; Zhang C; Wang Q; Han P; Wei Q; Bao Y
    Nutr Cancer; 2024; 76(1):80-88. PubMed ID: 37941300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of a novel immune and nutritional score on prognosis in patients with upper urinary tract urothelial carcinoma following radical nephroureterectomy.
    Liu J; Lai S; Wu P; Wang J; Wang J; Wang J; Zhang Y
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10893-10909. PubMed ID: 37318591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of preoperative lymphocyte-related systemic inflammatory biomarkers in upper tract urothelial carcinoma patients treated with radical nephroureterectomy: a systematic review and meta-analysis.
    Shao Y; Li W; Wang D; Wu B
    World J Surg Oncol; 2020 Oct; 18(1):273. PubMed ID: 33097052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of preoperative body mass index on prognosis for patients with upper urinary tract urothelial carcinoma treated with radical nephroureterectomy.
    Chen JC; Huang TH; Wei TC; Huang IS; Fan YH; Lin CC; Lin TP; Chung HJ; Lu SH; Kuo JY; Wu HHH; Chang YH; Lin ATL; Huang WJ; Huang EY
    World J Urol; 2023 Dec; 41(12):3575-3583. PubMed ID: 37924334
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.